Filing Details
- Accession Number:
- 0001209191-15-074184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-05 20:15:12
- Reporting Period:
- 2015-10-01
- Filing Date:
- 2015-10-05
- Accepted Time:
- 2015-10-05 20:15:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-10-01 | 700 | $102.30 | 126,815 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-01 | 900 | $103.28 | 125,915 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-01 | 5,159 | $104.45 | 120,756 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-01 | 5,058 | $105.41 | 115,698 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-01 | 600 | $106.07 | 115,098 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $102.30 (range $101.68 to $102.66).
- Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $103.28 (range $102.71 to $103.60).
- Open market sales reported on this line occurred at a weighted average price of $104.45 (range $103.89 to $104.88).
- Open market sales reported on this line occurred at a weighted average price of $105.41 (range $104.91 to $105.90).
- Open market sales reported on this line occurred at a weighted average price of $106.07 (range $105.99 to $106.12).
Billionaire Hedge Funds
